Graduate
Jeff D’Agostino is founder and CEO of 206 Ortho, a company that’s developing high-strength, biodegradable composites and implants that could mend broken bones and then resorb without leaving a trace. In July, the business received two additional patents for a bio-inspired composite that can be used in place of metal implants and doesn’t require surgical removal. Jeff says Babson played an influential role in 206 Ortho, noting, “The Babson community truly had a significant impact on how we shaped the business.”